Skye Bioscience, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $4.97M.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $2.98M.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $4.97M, a 66.78% increase from fiscal 2023.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $2.98M.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $114.00K, a 49.68% decline from fiscal 2015.
- Skye Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $226.56K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $4.97M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $4.97M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $2.98M 10-K · filed 2025-03-20 | |
| 2023-03-31 | $2.98M 10-Q · filed 2024-11-07 | |
| 2016-12-31 | $114.00K 10-K · filed 2017-03-10 | |
| 2015-12-31 | $226.56K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |